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a b  s  t  r a  c t
Attenuated total  reflection-Fourier transform infrared  (ATR-FTIR)  imaging has  been  applied for  the  first
time  to monitor  the  redistribution  and release of  hGH from a range  of  PLGA/PLA  microparticles  during  a
set  of dissolution experiments  at 37 ◦C in D2O. The effect of gamma-irradiation,  a  common  sterilisation
method,  on hGH release kinetics  from  such  systems has  been demonstrated.  Increasing  the  gamma  dose
was shown to have  a profound  influence on the  nature  of the  release mechanism,  with  higher gamma
doses  leading  to a dramatic  increase  in the  initial burst  release  followed by  a  retardation  in the  sustained
release  and a lower total  level  of hGH release  over the dissolution  experiment. These  changes  were  shown
to  be  the  result  of a combination of factors; firstly,  via scanning  electron microscopy  (SEM),  gamma-
irradiation  was shown to  strongly influence the  morphology  of the  PLGA/PLA  microparticles;  reducing
their  overall porosity  and reducing  the  available  surface area,  whilst  forcing some  of the  entrapped  hGH to
the  microparticle  surface.  Secondly,  from  FTIR measurements,  gamma-irradiation  was shown to  increase
the  number  of oxygenated  components  in the  Poloxamer 407  excipient,  by  a process of chain  scission,
thereby  increasing the  strength  of interaction  between the  microparticle  and  the  entrapped hGH.
©  2014  Published by  Elsevier B.V.
1. Introduction
Peptides and proteins cannot readily be delivered by traditional
routes such as by  oral, nasal or pulmonary delivery due to their high
molecular weight, hydrophilicity and labile nature. Consequently
such drugs are normally administered by  injection to therapeu-
tically tackle a number of conditions. To treat growth hormone
(hGH, a 22 kDa protein) deficiency in  children with hypopitu-
itary disorders and in adults, this normally results in the need
for daily injections for a period of several years which is par-
ticularly challenging for children. Encapsulation of drugs such as
proteins in biodegradable polymer matrices, such as PLGA for sus-
tained release, offers a  solution to  the problem of delivery of drugs
effectively to the patient with minimal inconvenience and also con-
trolling drug’s release into the body over time, thereby removing
the necessity for frequent administration and improving patient
compliance and treatment efficacy.
 Selected paper presented at 7th International Conference on Advanced Vibra-
tional Spectroscopy, Kobe, Japan, August 25–30, 2013.
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A sustained release formulation of hGH can be achieved by its
encapsulation into injectable microparticles of biodegradable and
biocompatible polymers such as PLGA or  PLA. After injection the
encapsulated microparticle slowly releases the hGH via a degrada-
tion mechanisms of the polymer to lactic or glycolic acid which are
rapidly cleared from the body via the renal system.
To date solvent-based methods such as emulsification have
been most often used to manufacture PLGA based microparticle
drug delivery systems. However, the use of solvents can lower
the biological activity of any encapsulated protein or peptide
through degradation at phase boundaries [1]. One route to  over-
come these difficulties is to use supercritical carbon dioxide (scCO2)
that removes the need for solvents during processing, such as
in  the PGSS (particles from gas saturated solutions) method for
the production of sustained release systems including polymer
matrix microparticles [2].  Novel sustained release formulations of
hGH prepared by supercritical fluid processing of PLGA/PLA (the
CriticalMixTM process) were produced in the form of microparticles
for subcutaneous injection [3].  We  have taken a  formulation that
has been evaluated in vivo in rats and monkeys, showing up to  two
weeks more of efficacious hGH release compared to a daily injec-
tion of soluble hGH, and investigated its real time release using
ATR-FTIR imaging for the first time. This study also evaluates the
effect of -irradiation on the physical and chemical structure of  the
0924-2031/$ – see front matter © 2014 Published by Elsevier B.V.
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microparticles and attempts to  draw links between chemical and
morphological changes and the in vivo release of the entrapped hGH
from single microparticles.
Pharmaceutically relevant microparticles for parenteral use
must be well characterised in  terms of their size range, morphology
and function. It is  widely understood that the chemistry and mor-
phology of microparticles have a degree of interdependence as the
morphology of microspheres can vary depending on their chemi-
cal state after preparation. This therefore can strongly affect drug
release behaviour from microspheres [4–6].
Often, pharmaceuticals have to be sterilised before use and for
polymeric microparticle drug delivery systems, -irradiation is  a
well-established method to achieve this [6,7].  Prior to  sterilisation
of pharmaceutical products using -irradiation, it is  essential to
determine any effects that this process may  have on the materials,
as each polymer reacts differently to  ionising radiation. Therefore
the  maximum dose that can be administered to  sterilise the product
must to be validated.
Fourier transform infrared (FTIR) spectroscopic imaging facil-
itates spatiotemporal images of individual components of multi-
component systems under dynamic conditions such as dissolution
[8]. It has become a  popular spectroscopic imaging approach,
particularly for pharmaceutical research, as it allows not only moni-
toring the physical and chemical changes of individual components
over time, but also gives quantitative information such as drug
release rate and polymer matrix degradation rate from the same
experiment [8–10].
Collecting thousands of IR spectra simultaneously using a 2D
focal plane array detector in which each pixel acts as an individual
detector, a stack of 2D images at a range of mid-IR energies can be
generated within a  few minutes.
The application of the attenuated total reflectance (ATR) samp-
ling technique in FTIR imaging has been increasingly reported
particularly in pharmaceutical research [11,12] as it is  advanta-
geous compared to transmission and transflection FTIR mainly in
that the shallow (2–10 m)  depth of penetration (i.e. the depth at
which the electric field amplitude is attenuated to e−1 of its initial
value at the sample surface) of IR light in  to the sample facilitates the
visualisation of formulations within aqueous media (as the water
bands cannot suppress the signal from the sample as a  result of
this shallow penetration depth) and species can be probed in  their
natural state as no sample preparation is  necessary [13].
Micro-ATR-FTIR imaging with a  Ge internal reflection element
(IRE) provides higher spatial resolution when compared to  trans-
mission and transflection measurements but with a much smaller
field of view [14].  Consequently, ATR-FTIR imaging in macro mode
in which the infrared beam from the spectrometer is passed
through the IRE and collected at the FPA without the use of a  micro-
scope is more convenient compared to micro-ATR as it provides a
larger field of  view and readily facilitates the use of a temperature
controlled environment for studying dynamic systems [15].
FTIR spectroscopy has been used for studying the interactions
of carbohydrates with dried proteins [16], assessing the integrity of
the hGH encapsulated in PLGA by spray-freeze-drying and water-
in-oil-in-water double emulsion methods [17] and assessing the
effect of excipients in lysozyme and BSA loaded microspheres
prepared by a double-emulsion technique [18].  The lysozyme dis-
tribution in microtomed PLGA microspheres prepared by a  w-o-w
solvent evaporation method has been studied by  FTIR imaging
in transmission mode and the second derivative protein amide I
band images shown a  homogenous distribution of protein [19].
The use of real time FTIR imaging for characterisation of a drug
delivery system [9] and dissolution of tablets [20,21] has been
demonstrated. Although distinct sample-solvent interfaces along
one axis of the field of view were monitored and release and redis-
tribution of various active pharmaceutical ingredients (APIs) were
investigated in  these FTIR imaging studies, there is  no litera-
ture regarding demonstration of the application of real time FTIR
imaging to (i) study the release of proteins or peptides from
biodegradable microparticles in situ and (ii) the assessment of  the
effect of -irradiation on stability of PLGA microparticles and on
the release of the protein from the microparticles, therefore our
study aims to address these aspects of vibrational spectroscopy
applied to pharmaceutical research. Generally, kinetic processes
such as release (including the burst release phenomenon, which
is critically important for assessing sustained release from drug
delivery devices) and matrix degradation in  protein based API
loaded biopolymer microparticles are monitored by  a combination
of various conventional methods including; differential scanning
calorimetry (DSC), gel permeation chromatography (GPC), x-ray
diffraction and infrared (IR) absorption spectroscopies [6], nuclear
magnetic resonance (NMR) and electron paramagnetic resonance
(EPR) spectroscopies [5] and UV–vis spectrophotometry [3] on bulk
samples (i.e. multiple microparticles). This paper demonstrates
the possibility of obtaining such important quantitative chemical
information by using FTIR spectroscopic imaging alone on a single
microparticle which allows the morphological visualisation of the
kinetic processes involved, which is not  available by bulk methods.
2.  Experimental
2.1. Materials
PLGA RG502H (50:50 lactide:glycolide, I.V. 0.16–0.24,
Bohringer-Ingleheim) with an inherent viscosity of 0.16–0.24 dl/g,
PLA R202H (100:0 lactide:glycolide, I.V. 0.16–0.24, Bohringer-
Ingleheim), with an inherent viscosity of 0.16–0.24 dl/g,
pharmaceutical grade CO2 (BOC Special Gasses) were used as
received. hGH was kindly donated by Bioker (Sardinia, Italy) and
Poloxamer 407 (Lutrol® F127) was  obtained from BASF (Lud-
wigshafen, Germany). D2O (613398-10G, min. 99.996 atom) and
bee’s wax (243248-100G) were purchased from Sigma–Aldrich
Company Limited, UK. Technovit 7100 embedding resin kit was
purchased from Kulzer & Co., Germany.
2.2. Preparation of microparticles using scCO2 processing
The method of PGSS (particles from gas saturated solutions) uses
the ability of scCO2 to depress the glass transition and melting tem-
perature of biodegradable polymers at ambient temperatures and
moderate pressures. scCO2 acts effectively as a  molecular lubricant,
thus liquefying polymers at temperatures significantly lower than
those typically needed. The near ambient temperatures together
with the absence of any aqueous or organic solvents makes the PGSS
method particularly suited to the processing of thermally or solvent
labile proteins and peptides, with the advantage that they can be
encapsulated with 100% efficiency with no protein degradation or
loss of activity.
A formulation of hGH loaded PLGA/PLA microparticles were pre-
pared using a  CriticalMixTM process by adding 2 g of  pre-weighed
combination of spray dried hGH (10%, w/w of the formulation),
PLGA and PLA in  90:10 ratio respectively (81%, w/w  of the for-
mulation) and GRAS excipient, Poloxamer407 (9%,  w/w of the
formulation), to the PGSS apparatus which was sealed and pres-
surised with CO2 to 700 psi (48 bar) and once heated to above 32
◦C
the pressure was increased to 2030 psi (140 bar). The scCO2was  dis-
solved into the liquefied mixture which was then stirred at 150 rpm
for 1 h,  after which time stirring was stopped and the homoge-
nous mixture was depressurised through a  nozzle generating free
flowing microparticles into a  collection chamber [3].
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Fig. 1. (a) White light image of a microparticle placed on the ATR crystal prior to  starting the experiment. (b)  Schematic of the dissolution experiment; the anvil applies
sufficient  pressure to  ensure good contact between the particle and the ATR crystal, whilst making sure D2O can only access the particles from the sides.
2.3. Sample preparation for  micro-ATR-FTIR imaging
hGH loaded PLGA/PLA microparticles were embedded in
a hydroxyethyl methacrylate based resin (Technovit 7100) as
described by van de Weert et al. [19] and sliced to  4 m thickness
using a Reichert-Jung Ultracut E ambient ultramicrotome with a
glass knife.
2.4. Scanning electron microscopy
To obtain topographic contrast of the microspheres before and
after irradiation, scanning electron microscopy (SEM) was per-
formed using a FEI NOVA 200 NanoSEM. Images were formed using
the secondary electron signal with a  spatial resolution of ∼2  nm.
The sample was sprinkled onto an adhesive carbon tab on an alu-
minium stub and sputter coated with gold (∼20 nm) in an Argon
atmosphere.
2.5. -Irradiation
Raw polymers and scSO2 produced microparticle formulations
were irradiated by using 60Co  as irradiation source (Synergy Health
PLC, Swindon, UK) at a few kGy/h dose rates ensuring a targeted
total dose in accordance with the ISO 11137 standard. The sample
temperature was  kept at near  room temperature during irradiation
using thermometric controls. 30 mg of the polymer samples were
sealed in a glass container and irradiated at 25 and 100 kGy total
dose in air.
2.6. ATR-FTIR spectroscopy
ATR-FTIR spectra were collected on a  Thermo Nicolet Nexus
instrument as single beam spectra by  co-adding 128 scans at a
spectral resolution of 4 cm−1 and ratioed against the single beam
spectrum of the blank ATR crystal at room temperature.
2.7. Micro-ATR-FTIR imaging
Micro-ATR-FTIR images were collected with the setup that  con-
sists  of an Agilent 680-IR FT-IR spectrometer operating in  rapid
scan mode attached to an Agilent 620-IR microscope with a  Ge
ATR crystal fitted on to  a  15×  Cassegrain objective and a  liquid
nitrogen cooled mercury cadmium telluride focal plane array
detector MCT-FPA (64 × 64 pixels).
Images were collected with a  4 cm−1 spectral resolution in the
mid-infrared range (3800–950 cm−1) co-adding 64 scans for both
background (Ge crystal in  air) and samples. The high refractive
index (4) of the germanium crystal allowed a spatial resolu-
tion of ∼4 m within the ∼64  m × 64 m field of view for this
setup.
2.8. Macro-ATR-FTIR imaging of drug release from individual
microparticles
Mid-infrared (3800–950 cm−1) spectroscopic imaging data in
Macro-ATR mode were acquired using an Agilent 680-IR FT-IR spec-
trometer attached to a  large sample (LS) external compartment
holding a  Golden GateTM Imaging Single Reflection ATR Accessory
(Specac Ltd.) which has a  Diamond internal reflection element with
corrective optics that adjusts the plane of best focus to sit on the
crystal surface minimising any distortion. The infrared beam from
the spectrometer was  projected directly on to a  liquid nitrogen
cooled MCT-FPA (64 × 64 pixels, 10 m × 10 m pixel size) after
passing through the ATR sampling accessory. This ATR-FTIR imag-
ing setup was capable of simultaneously collecting 4096 spectra
from an image area of 640 m × 640 m with an angle of  inci-
dence of the infrared beam of 45◦ and numerical aperture (NA) of
0.32.
A single microparticle was placed on to the centre of the square
surface of the ATR crystal with the aid of a 40×  binocular micro-
scope. A uniform contact between the particle and the crystal with
minimal deformation was obtained applying sufficient pressure
to the auto-level sapphire anvil [22].  Minimal deformation was
ensured, such that the same particle could be picked up using the
same needle without leaving any residue on  the ATR crystal. After
collecting a  ‘dry’ image at 37 ◦C, ∼2  ml  of D2O  that  had been pre-
heated to 37 ◦C was injected into the cell in such a way that access
to the particle was limited to  the sides only as shown in  Fig. 1. The
raw images were collected in  rapid scan mode taking ∼5  min  using
the Agilent Technologies’ ResolutionsPro FTIR Spectroscopy soft-
ware version 5.2.0(CD846) with 128 co-added scans at an 8 cm−1
spectral resolution, and processed by ratioing against a  background
of the blank ATR crystal with 256 co-added scans also collected at
37 ◦C.
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Fig. 2. (a) An illustration of a  typical, CriticalMixTM processed microparticle where strands represent mixed polymers and dots represent the homogenously distributed hGH
particles.  (b) White light image of 3 microparticles embedded in resin and microtomed to  4 m thickness (c) Micro ATR (Ge) peak height images from the area shown with
the  box in the white light image, showing resin (1724 cm−1), PLGA/PLA (1755 cm−1) and hGH (1650 cm−1) from left  to  right respectively.
2.9. Data processing
Hyperspectral image cubes were processed using Malvern
Instruments’ ISys 5.0 chemical imaging software. Raw processed
image files were cropped between 1820 and 1000 cm−1,  a  region
which contains a  number of characteristic bands associated with
PLGA/PLA polymers, protein amide I  band ∼1650 cm−1 and the
ı(OD) band of D2O  at ∼1207 cm
−1.
A Savitzky–Golay second derivative with a  polynomial order of
3 and filter length of 29 was applied to cropped imaging data in
order to eliminate baseline drift. Second derivative images were
then vector normalised in  order to remove systematic discrepan-
cies such as variations in detector sensitivity or sample contact and
therefore to minimise intensity (Log(1/R)) variance.
3. Results and discussion
ATR-FTIR spectroscopy facilitates the generation of chemical
fingerprints of individual species and permits the monitoring of
reaction and/or release kinetics due to the fact that  unique molec-
ular vibrations within a  mixture can be  assigned to  different
components within that mixture. As  the evanescent wave effec-
tively limits sample thickness, strongly absorbing molecules such
as water can be observed facilely and this opens up  the opportu-
nity to observe systems where a  sample is placed in  contact with
an aqueous medium. FTIR imaging permits the collection of tem-
poral images of such multicomponent systems in  aqueous media
in which changes in  the chemistry of such species can be spatially
resolved in  real time. In pharmaceutical research, this hyperspec-
tral imaging approach using non-destructive IR light, particularly
in  ATR  mode requiring no sample preparation or  the use of  dyes or
chemical labels, is a  unique toolbox for formulation design allow-
ing characterisation of static samples, with as high as ∼4 m spatial
resolution in micro mode, whilst facilitating the monitoring of
dynamic physical and chemical changes occurring within formu-
lations [10].
The CriticalMix process is thought to produce an homoge-
nous distribution of API throughout the porous microparticles as
Table 1
Vibrational assignments for PLGA 50/50, PLA, Poloxamer 407, resin, D2O and hGH within the finger print region (1820–1000 cm
−1); as antisymmetric, s  symetric, ı bending,
  rocking,  stretching,  twisting, ω  wagging, all given in cm−1 .
PLGA PLA  hGH Poloxamer 407 Resin D2O Assignment
1745 1745 1727 (C O)
1658 Amide I, (C O)
1635 ı(OH)
1540 Amide II, ı(NH)
1452  1450 1450 1466 1484 ıas(CH3)
1422  1450 ı(CH)
1394  1394 1395 ω(CH)
1381  1379 1374 ıs(CH3)
1360  1362 1304 1359, 1341 1323 ı(CH)
1270  1266 1280, 1241 1274, 1249 (CH2)
1245  as(PO)
1207 ı(OD)
1167  1184 1146 1144, 1100 1154 as(COC)
1131  1127 as(CH3)
1104  s(PO)
1086  1084 1077 1074 s(COC)
1048  1045 1049 1059 1020 (C CH3)
990 s(PO)
957  957 942 962 948  (CH3)
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Fig. 3. False colour ATR-FTIR images of (a) non-irradiated, (b) 25  kGy -irradiated and (c) 100 kGy -irradiated microparticles showing second derivative peak height
distribution of PLGA at 1755 cm−1 , hGH at 1650 cm−1 and D2O at 1207 cm
−1 as a function of time.
depicted in the illustration in  Fig. 2(a). This was evaluated by
microtoming a 4  m section of a  group of microparticles within an
embedding medium highlighted by the red box in  Fig.  2(b). Using
mid-IR imaging in micro-ATR mode utilising a  Ge ATR crystal which
provided a spatial resolution of ∼4 m within ∼64 m × 64 m
field of view, the distribution of polymer and API within these
particles was determined.
Table 1 shows the list of important peaks included in finger-
print region of the ATR-FTIR spectra obtained from pure samples.
From this table, it can be seen that the most intense poloxamer
407 peaks overlap with PLGA/PLA peaks however very strong peaks
are readily available at discrete wavenumbers for the rest of the
samples. Also it will be discussed later on in  the macro-ATR images,
the ı(OD) of D2O  also becomes distinct when a second derivative is
applied.
Fig.  2(c) shows the integrated peak height distribution of  the
resin at 1727 cm−1,  PLGA/PLA at 1755 cm−1 and hGH at 1650 cm−1
from left to right respectively. The distribution of PLGA/PLA and
hGH, middle and right hand side images in Fig. 2(c) respectively,
clearly show a  good correlation between the high intensity (red)
regions of PLGA/PLA and hGH. This is  in  contrast to the resin distri-
bution, which shows an anti-correlation to both components. This
is  strong evidence of the homogenous distribution of hGH protein
with in the PLGA/PLA microparticle 
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Fig. 4. SEM images showing typical (a) non-irradiated, (b) 25 kGy and (c) 100 kGy
-irradiated microparticles.
FTIR imaging in macro-ATR mode has been demonstrated
to facilitate imaging a  variety of temporal information such as
the morphological evaluation of different components, redistri-
bution and/or release of species at polymer/solvent interfaces
and the occurrence of new species during chemical reactions
under the conditions of interest [10,12,15,23]. However release
of active pharmaceutical ingredients (APIs) form single polymeric
microparticles and monitoring the redistribution of API ‘inside’
a microparticle has not previously been studied by  ATR-FTIR
imaging.
To investigate the morphological and chemical evolution of a
protein loaded polymeric microparticle in real time using ATR-FTIR
imaging in macro mode and to explore the effect of -irradiation on
such protein loaded PLGA/PLA microparticles, we  have taken 3 sin-
gle microparticles that had been subjected to -irradiation at doses
of 25 and 100 kGy, as well as a control sample (same formulation
without -irradiation) and monitored their interaction with water
as a function of time at 37 ◦C. The experiment is setup in  such a  way
that the interaction between the particle and water will only occur
at the interfaces that we are monitoring, effectively creating a 2D
experiment.
Fig. 3(a) shows six false colour images obtained by plotting the
intensity distribution of the PLGA/PLA ester carbonyl (1755 cm−1),
protein (hGH) Amide I (1650 cm−1)  and D2O  ı(OD) (1207 cm
−1).
The first column of images show  the distribution of  polymer,
hGH and D2O, respectively, before the dissolution experiment was
started and are therefore labelled ‘dry’. From these ‘dry’ images a
homogenous distribution of hGH within the polymer matrix can
be observed once again, complementing the micro-ATR image of
the sliced sample shown in Fig. 2(c). Therefore we have confidence
that the surface (up to ∼10 m)  we are probing with IR light in
this experiment is representative of internal structure of the micro-
particle, as expected from the CriticalMixTM manufacture of drug
loaded microparticles [2,3].
The first row of images shown in  Fig. 3(a) shows the change
in the distribution of the PLGA/PLA component of the control,
i.e. un-irradiated, hGH loaded PLGA/PLA microparticle. To a first
approximation this set of images can be  used to  monitor the
dimensional changes of the microparticle during the dissolution
experiment. In the PLGA/PLA image collected after 1 h,  image set
there is evidence of an interface layer of hydrated PLGA/PLA around
the particle even at this short time, with a  decreasing D2O con-
centration from the aqueous dissolution medium towards the
particle centre and some evidence of particle swelling. Within 24  h
the PLGA/PLA microparticle (red) appears to  have swollen fur-
ther, becoming larger, whilst still being surrounded by  a hydrated
PLGA/PLA layer (yellow), and over time the size of  the particle
stays almost the same in  terms of visual representation. The bot-
tom row of Fig. 3(a),  shows the complementary image data set of
D2O distribution as a  function of time. These images show a strong
anti-correlation with the PLGA/PLA image dataset and verify the
significant amount of swelling in this system, as one might expect,
due to the inclusion of the excipient Poloxamer 407 at 9% (w/w)
in  the formulation, making the microparticles more hydrophilic
[24,25].  It is worth noting that after ∼1 h,  D2O  is present, albeit at
a low level, everywhere within the particle, almost certainly due
to  a  combination of the particle hydrophilicity and its porosity.
Over the duration of this experiment (334 h, ∼14 days) we  cannot
observe any major evidence of ‘shrinking’ of the PLGA/PLA particle,
implying this observation would require a  much longer sampling
period, perhaps several months at 37 ◦C.  This not only shows the
well-documented suitability of PLGA and PLA to  act as biodegrad-
able drug carriers, providing sustained release for several weeks
to  months, but also suggests that protein release from this system
is dominated by diffusion rather than erosion, during the first 2
weeks, which may  be expected due to the system being porous.
The hGH distribution images (middle row, Fig. 3(a)), were gener-
ated by plotting the Amide I peak height at ∼1650 cm−1, show a
change in the distribution at short times (<24 h)  as the polymers
are initially swollen and this is  followed by a  gradual decrease of
overall hGH intensity distribution as a  function of time. It is worth
noting that the dimensions of the hGH rich region are somewhat
smaller than their polymer and D2O  counterparts. One explana-
tion for this is that the hGH is being lost into the D2O  media at the
interfaces.
Fig. 3(b) shows the equivalent false colour infrared images
for the data described in Fig. 3(a), obtained from a hGH loaded
PLGA/PLA microparticle that has been subjected to 25 kGy -
irradiation. The PLGA/PLA and D2O distribution maps are quite
similar to  those shown in Fig. 3(a), and the hGH distribution images
are once more much smaller than both the polymer and D2O
images. Any change to the colour intensity of the hGH rich region as
a  function of time after 24 h is  more difficult to ascertain by visual
inspection.
Fig. 3(c) shows analogous image data sets for a  hGH loaded
PLGA/PLA microparticle that  has been subjected to 100 kGy -
irradiation, and although at first glance the polymer and D2O
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Fig. 5.  (a)Release profiles obtained from 5 × 5 pixels regions of images of non-irradiated and -irradiated microparticles undergoing dissolution. Error bars indicate standard
deviation between 3 ROIs used to obtain each data point.(b) The first 4 h  data shown in (a), to provide clarity error bars are removed.
distribution images look similar to  those depicted in  Fig.  3(a) and
(b), a remarkable rapid release of hGH around the microparticle can
be seen in the 1 h image and to  a  lesser extent, in 24 h image, this
may  be due to the hGH being dissolved in  the surrounding media
during the ensuing 23 h.  The subsequent time resolved hGH distri-
bution maps contain fewer red pixels (i.e. high intensity regions)
within the hGH images compared to the earlier time points, there-
fore it can be assumed that the most of hGH has been released
during this initial hydration process; the so called burst release
effect. Subsequent time resolved images show a slow reduction in
intensity of the hGH distribution maps. Closer inspection of the
D2O distribution maps, show a higher concentration of D2O (as
denoted by the blue/green colour) within the body of the micro-
particle from 1 h when compared to both the un-irradiated and
25 kGy -irradiated hGH loaded microparticles.
It is clear that both geometry and morphology could have a
strong influence on the release characteristics of a  hGH loaded poly-
mer  microparticle, with porosity in  particular likely to determine
the rate of hydrolytic degradation and therefore drug release from
such systems [26]. SEM was used to explore the morphology of the
non-irradiated and irradiated microparticles. SEM is  a tool that is
readily applied to the microscopic characterisation of particles and
other polymer surfaces [27].
Fig. 4 shows the SEM images of (a)  non-irradiated, (b) 25 kGy
-irradiated and (c) 100 kGy -irradiated microparticles. There
are clear differences in  morphology between the different micro-
particles, the -irradiated particles have a smooth surface and
appear to be non-porous but with significant amounts of irregular
particles, possibly hGH, attached to the surface. However the
non-irradiated particle has a rough, non-uniform and porous mor-
phology with inherently higher surface area than the -irradiated
microparticles.
The use of FTIR imaging data to  monitor drug release has been
validated previously using an experimental setup that  combined a
UV detector to monitor the release of API from a  tablet subjected
to water flow during macro ATR-FTIR imaging and compared this
to  conventional dissolution test data of the same sample type [28].
Release profiles obtained from the two methods were shown to be
very similar. By conducting measurements in situ using FTIR  imag-
ing, we can follow chemical changes by monitoring specific IR bands
of components in a  fixed area in  a temporal image set and quan-
tify the relative amount of that species released during a dissolution
process. In each set of temporal images; non-irradiated, 25 kGy  irra-
diated and 100 kGy irradiated, we have chosen 3 square regions
(50 m × 50 m)  of interest (ROI) from hGH rich zones within the
microparticles by visually assessing the 1 h images in each data
set. By calculating the decrease in  area under amide-I peak at
∼1650 cm−1 in  the binned, normalised temporal spectra from the
ROIs we  can generate a  release profile by assuming the decrease in
hGH signal at time = t (compared to  hGH signal at time =  0) is pro-
portional to hGH released at that time point. Using this approach
it is feasible to  generate a  dissolution plot that is analogous to a
release profile from a  standard USP I UV-dissolution experiment.
Fig.  5(a)  shows the 3 release profiles obtained from tempo-
ral image sets of 0, 25 kGy and 100 kGy -irradiated hGH loaded
microparticles shown in  Fig. 3(a), (b) and (c), respectively, includ-
ing additional time points for images not shown. Data points in
Fig.  5(a) are generated from the average of overall intensity from
the 3 binned and normalised ROIs and error bars indicate standard
deviation. It  is evident that  in  Fig. 5(a) for all three release profiles
there are two  distinct regions; firstly a  rapidly increasing initial
period followed by a  second phase that almost represents a  first
order line profile with a slope close to zero.
In Fig. 5(b), this initial period in Fig. 5(a)  up to  4 h, is  plotted once
again for better visualisation for evaluation of the burst release phe-
nomenon. The release profile from the non-irradiated hGH loaded
microparticle is showing an initial burst within the first few hours
followed by a  slower rate release for the duration of the experi-
ment reaching a plateau sometime after ∼72 h.  This release profile,
obtained from a  single microparticle, is very similar to the release
profile obtained by standard dissolution testing using UV detec-
tion [3] for the 10 mg  of a  similar formulation, both suggesting a
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Fig. 6. ATR-FTIR spectra of non-irradiated and -irradiated; (a)formulation, (b)hGH, (c)PLGA50/50, (d)PLA and (e)Poloxamer 407.
rapid initial release based on diffusional escape through the pores
existing in the microparticles, followed by  a slower sustained
release based on degradation of the polymers, indicating a  high
encapsulation efficiency (∼100% [3]).
Fig. 5(a) also indicates that the total hGH release from the irra-
diated formulations is lower overall and particularly after reaching
the plateau levels compared to the non-irradiated microparticle.
This may  be due to changes in  the particle morphology, changes in
the chemistry of the microparticle or  some combination of the two.
The hGH release profile from the hGH loaded PLGA/PLA micro-
particle which has undergone 100 kGy  irradiation, once again,
shows a markedly high initial burst release particularly within the
first 2 h (Fig. 5(b)) which was also evident in  Fig. 3(c) in the 1 h
image compared to the rest of the images in  that row, indicat-
ing an immediate and high release of hGH that is too fast to  be
a polymer degradation or diffusion controlled. -irradiation caus-
ing this kind of an increased burst effect was  also reported by
Carrascosa et al. [29] who investigated recombinant human insulin-
like growth factor-I (rhIGF-I) release from PLGA microspheres by
SEM, UV-dissolution and differential scanning calorimetry (DSC).
It  is also evident from the SEM images that the 100 kGy irradiated
hGH loaded microparticle has a  smooth surface and appears have
a non-porous morphology (Fig. 4(c)) compared to the very porous
non-irradiated particle (Fig. 4(a)), therefore the initial burst from
100 kGy -irradiated particle is likely to be occurring due to surface
bound hGH, that is made available at the surface of the microparti-
cle during the -irradiation process. Unlike both the un-irradiated
and the 25 kGy -irradiated sample, following its burst release, the
100 kGy -irradiated formulation shows zero measurable release
after 48 h.  For the non-irradiated and 25 kGy -irradiated micro-
particles it takes about up  to 3 days for this to be the case. It is  also
worth remarking that the total amount of hGH  that is  being released
after the initial burst appears to be  much less than is  observed in
the other microparticles.
The release from the 25 kGy -irradiated formulation shows
similarities to  both the non-irradiated and the 100 kGy -irradiated
microparticles; its initial burst profile is similar to  the 100 kGy -
irradiated formulation, indicating high protein availability at its
surface, but it takes longer to  reach a  plateau similarly to  that
observed in  the non-irradiated microparticle and the total amount
of protein released appears to  be in between that of non-irradiated
and 100 kGy -irradiated samples, indicating an intermediate level
of protein release due to  degradation of the polymers at longer
times. Considering the morphology of the 25 kGy -irradiated
microparticles (Fig. 4(b)) being very similar to typical 100 kGy -
irradiated particles; non-porous and smooth, a  lower amount of
release at longer times when compared to non-irradiated particles
could be expected. This is  a  finding which is in  agreement with
that of Dorati et al. [5] who studied effect of -irradiation on PLGA
microparticles containing ovalbumin using a  combination of  NMR,
SEM and EPR.
Single point ATR-FTIR spectroscopy, collecting the average IR
signal from a sample facilitates very high signal to noise ratio
(S/N) in each spectrum when compared to  imaging with an FPA
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IR detector, hence may  provide much more detailed vibrational
information that may  not  be readily obtained from data collected
using FPA detectors in  imaging mode. Therefore in order to assess
the effect of -irradiation on the chemistry of the microparticles
and therefore infer their influence on hGH release, we also con-
ducted ATR-FTIR measurements on bulk samples (both -irradiated
and un-irradiated).
Fig. 6 shows the fingerprint region (1820–1000 cm−1) of ATR-
FTIR spectra of the non-irradiated, 25 kGy -irradiated and 100 kGy
-irradiated hGH loaded micropartcles and pure components of
the formulation. No noticeable change in  the infrared spectra was
observed as a result of being subjected to -irradiation on the hGH
loaded microparticles, the PLGA, PLA or hGH components. (Fig. 6
(a)–(d)).
However, close inspection of the data collected from the Polox-
amer 407 samples showed the appearance of a carbonyl band with
increasing intensity proportional to the applied  dose, indicat-
ing -irradiation induced degradation. Poloxamers are excipients
that are used in drug carriers, such as PLGA micro or nano parti-
cle formulations, to  enhance the release of drugs [24,25]. Therefore
the degradation of Poloxamer407 is  likely to have an impact on
the release rate of the hGH loaded samples. When subjected to -
irradiation, polymers may  undergo chain scission or cross-linking.
Dorati et al. [4] have shown that for PEG based polymers at higher -
irradiation doses, chain scission is the predominant process leading
to  a greater number of oxygenated species and shorter PEG chain
lengths. Increasing the number of oxygenated species in  a  micro-
particle is likely to have a  significant impact on the dynamics of
hydration due to an increase in the hydrophilicity and the strength
and nature of interactions occurring between the species contained
within that microparticle. In this instance, the increase in the num-
ber of oxygenated species appears to have significantly increased
the rate of hydration, leading to a  faster and more pronounced ini-
tial burst release of hGH. The increase in the number of oxygenated
species within the microparticle may  also influence the strength of
interactions between the polymeric species and the encapsulated
hGH, leading to a  retardation of the sustained release rate after the
initial burst. These findings are in agreement with those of Dorati
et al. [5] who ascribed a  retardation in the release rate of OVA from
-irradiated PLGA-PEG microspheres, when compared to their un-
irradiated counterparts, to be due to a  combination of changes in
the morphology of the microparticles and an increase in the magni-
tude of the interaction between the polymer matrix and the protein.
Although our system is not identical to that  studied by  Dorati and
co-workers [5],  Poloxamer 407 is  a tri-block copolymer of PEG-PPG-
PEG, therefore we can anticipate the effect of -irradiation on these
hGH loaded microparticles to be quite similar.
4. Conclusions
ATR-FTIR has been shown to be a  successful method to  monitor,
in situ, the release of hGH from PLGA/PLA microparticles, providing
important information about the mechanism of release. Utilising
the chemical selectivity of the infrared methodology, hGH release
profiles, analogous to those obtained using standard dissolution
apparatus have been obtained for microparticles subjected to a
range of -irradiation doses. The release mechanism of hGH from
these microparticles has been elucidated with the release kinetics
changing as a result of modifications to the microparticle mor-
phology and chemistry during -irradiation. SEM analysis of the
microparticles indicated that -irradiation made them less porous,
reduced the surface area and forced some material, most likely
hGH to the surface. FTIR-ATR analysis of the individual microparti-
cle components, indicated that -irradiation was leading to chain
scission in  the Poloxamer 407 excipient, increasing the number of
oxygenated species within the microparticle and influencing the
strength of interactions between the entrapped hGH and the poly-
meric matrix. These findings are in  good agreement with work
conducted by Dorati et al. [5] and Carrascosa et al.  [29] on PLGA
based microparticles containing different protein based APIs.
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